Actinium Pharmaceuticals, Inc. (ATNM)
1.16
-0.02
(-1.69%)
USD |
NYAM |
Mar 02, 09:47
Actinium Pharmaceuticals Research and Development Expense (TTM) : 20.82M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Assertio Holdings, Inc. | 2.49M |
| Altimmune, Inc. | 67.72M |
| Aldeyra Therapeutics, Inc. | 25.66M |
| Avanos Medical, Inc. | 23.10M |
| ACADIA Pharmaceuticals, Inc. | 328.80M |